Skip to content

Australians for Mental Health

By API User

Social inclusion should be a mandatory performance target for local governments   Australians for Mental Health has urged decision makers to take action after the latest Australian Institute of Health and Welfare report stated loneliness was on the rise.    The report found 40% of people, or 2 in 5, reported feeling lonely in the … Continued

Urgent push to reduce emissions and costs, provide better patient care in Australia’s health system

By API User

Picture opportunity: 10am at The Alfred Simulation Centre, 89 Commercial Road Melbourne 3004 (Parking under The Alfred Centre, 99 Commercial Road) Leading Australian researchers and healthcare organisations have joined forces with federal and state health departments to address the health sector’s urgent need to reduce greenhouse gas emissions, lower health costs and provide better patient … Continued

Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models

By API User

Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions. High-quality biological patient data, enriched and integrated for use by AI agents. PARIS, FRANCE, GB / ACCESS Newswire / October 16, 2025 / Owkin today announces the launch of K Pro, its co-pilot bringing advanced agentic AI to biomedical research … Continued

AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Directors

By API User

Kay was instrumental in driving the successful development and commercialization ofXofigo®, the first and only approved alpha therapy to date SYDNEY, Australia – October 16, 2025 – AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Andrew Kay as Director and Chair-elect of its Board of Directors, … Continued

OncoSil Medical (ASX:OSL) First OncoSil(TM) treatment in Germany

By API User

Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) is pleased to announce the first patient treatment in Germany using the OncoSil™ device. The successful treatment was performed on 15 October 2025 at Universitätsklinikum Augsburg, a leading university hospital renowned for its excellence in oncology. This important milestone marks the commencement of OncoSil’s commercial activities in Germany, the … Continued